# @cnbci on TikTok

- **Type:** Video
- **Original URL:** https://www.tiktok.com/@cnbci/video/7610832963424636182
- **Gondola URL:** https://gondola.cc/posts/57549181-cnbci-tiktok
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/b7046bd674.jpg
- **Posted:** 2026-02-25T15:59:04.000+00:00
- **Account Owner:** CNBC International (@cnbci) — https://gondola.cc/cnbci

## Caption

Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most valuable company. But its troubles are stacking up and today the stock trades at just a quarter of what it did at its peak less than two years ago. These four charts show the scale of Novo Nordisk’s woes. #novonordisk #weightloss #glp1 #cnbc 

## Stats

- **Views:** 12,300
- **Likes:** 115
- **Shares:** 8
- **Comments:** 3

## Tags

glp1, novonordisk, cnbc, weightloss

---
Copyright (c) Gondola